"5호선 강동역 2번 출구 위치, 1588-4100, 하이브리드수술, 로봇수술, 청소년웰빙센터"

During the past decade, Kangdong Sacred Heart Hospital conducted 26 clinical trials. In the 10-year time frame, 26 clinical trials started and 10 clinical trials were completed, i.e. on average, 38.5% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 6 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kangdong Sacred Heart Hospital" #1 sponsor was "Seung-Jung Park" with 7 trials, followed by "Pfizer" with 6 trials sponsored, "Seoul National University Hospital" with 5 trials sponsored, "Boehringer Ingelheim" with 4 trials sponsored and "Asan Medical Center" with 4 trials sponsored. Other sponsors include 24 different institutions and companies that sponsored additional 25 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kangdong Sacred Heart Hospital" #1 collaborator was "CardioVascular Research Foundation, Korea" with 7 trials as a collaborator, "Medtronic" with 3 trials as a collaborator, "Chonnam National University Hospital" with 2 trials as a collaborator, "Kangdong Sacred Heart Hospital" with 2 trials as a collaborator and "Korea Otsuka Pharmaceutical Co., Ltd." with 2 trials as a collaborator. Other collaborators include 49 different institutions and companies that were collaborators in the rest 57 trials.

According to Clinical.Site data, the most researched conditions in "Kangdong Sacred Heart Hospital" are "Coronary Artery Disease" (11 trials), "Cerebral Infarction" (3 trials), "Hypertension" (3 trials), "Angioplasty, Transluminal, Percutaneous Coronary" (2 trials) and "Cardiovascular Disease" (2 trials). Many other conditions were trialed in "Kangdong Sacred Heart Hospital" in a lesser frequency.

Most popular intervention types in "Kangdong Sacred Heart Hospital" are "Drug" (34 trials), "Device" (11 trials), "Biological" (3 trials), "Other" (3 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Cilostazol" (4 trials), "Aspirin" (2 trials), "bococizumab (PF-04950615)" (2 trials) and "1-year DAPT" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kangdong Sacred Heart Hospital" are 53 trials for "All" genders.

Currently, there are NaN active trials in "Kangdong Sacred Heart Hospital". undefined are not yet recruiting, 5 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 32 completed trials in Kangdong Sacred Heart Hospital, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Kangdong Sacred Heart Hospital, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 12 trials, and there were also 3 trials that are defined as “Not Applicable".